SUBSCRIBE
SUBSCRIBE

Adaptive Biotechnologies

NEWS
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
Job Trends
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
February 17, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Adaptive Biotech Enters Drug Discovery With Launch of New Company, Adaptive Therapeutics
August 20, 2015
 · 
3 min read
Business
Will New CFO Take Adaptive Biotech Public?
August 11, 2015
 · 
2 min read
Job Trends
Seattle’s Adaptive Biotech Will Set Up Shop in New York
July 1, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
BioForest
Here’s What Juno Therapeutics Really Thinks About Local Rival Adaptive Biotech
May 29, 2015
 · 
4 min read
Job Trends
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees
May 21, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioForest
Adaptive Biotech Bags $195 Million In Largest Washington Fundraise This Year
May 6, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Adaptive Biotechnologies Banks $94 Million, Buys Bay Area’s Sequenta, Inc.
January 8, 2015
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results
August 2, 2023
 · 
11 min read
Business
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023
July 10, 2023
 · 
1 min read
BioForest
Adaptive Biotechnologies to Participate in Upcoming June 2023 Investor Conferences
May 24, 2023
 · 
1 min read
Business
Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
May 3, 2023
 · 
10 min read
BioForest
Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 27, 2022
 · 
1 min read
BioForest
Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting
December 10, 2022
 · 
10 min read
Business
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
November 3, 2022
 · 
11 min read
BioForest
Adaptive Announces Partnership with Epic to Increase Access to Minimal Residual Disease (MRD) Monitoring in Blood Cancers
October 11, 2022
 · 
7 min read
BioForest
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
September 12, 2022
 · 
4 min read
Business
Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
August 3, 2022
 · 
8 min read
Load More